About Daniel Halpern
Daniel Halpern is a chief executive officer and director at InSitu Biologics.
Experience
This experience comes from Daniel Halpern's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Halpern in the role, so the role may have started earlier or lasted longer.
InSitu Biologics, Inc. Current
CEO (2025 – Present)
Director
2025 – Present · Oakdale, MN
Develops non-opioid pain treatments for patients recovering from surgery.
FC
Fibralign Corporation
Business Development Executive
2020 – 2026
HL
Healthcare Investors, LLC
President
1995 – 2026
CI
Crystalline Medical, INc.
CEO
2022 – 2025
Key Colleagues at Startups
The people Daniel Halpern works with at each company, as listed on that company's latest Form D.
InSitu Biologics, Inc. · Form D/A, Nov 10, 2026
WT
William Taylor
Executive officer
SK
Sandi Klemann
Executive officer
RW
Robert Wilson
Member of the Board of Directors
GG
Greg Van Guilder
Director
IS
Ivan Shaw
Director